CTNM

CONTINEUM THERAPEUTICS INC

CTNM·21217B100·US·Common Stock·Healthcare - Biotechnology-13D/G

CTNM (CONTINEUM THERAPEUTICS INC) is held by 53 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($35.6M), FRANKLIN RESOURCES INC ($24M), BALYASNY ASSET MANAGEMENT L.P. ($22M). Net institutional sentiment: Bullish.

53
Holders
Avg rating(6 Elite)
$226.7M
Total Value
67% (57)
Fund Consensus
35 buying - 17 selling
CTNMSmart Money Verdict
View all
Held by 53 funds
6 elite
Who's Trading
InsiderLSLorrain Daniel S.Sell $400Jul 9, 2026
InsiderLSLorrain Daniel S.Sell $16KJul 8, 2026
InsiderSNStengone Carmine N.Sell $40KJul 8, 2026
ActivistBalyasny Asset Management L.P.Balyasny Asset Management L.P.7.4%May 15, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.4.0%May 15, 2026
InsiderLSLorrain Daniel S.Sell $51KMay 1, 2026
InsiderLSLorrain Daniel S.Sell $4KMay 1, 2026
ActivistMillennium Management LLCMillennium Management LLC5.1%Apr 17, 2026
InsiderLSLorrain Daniel S.Sell $56KApr 6, 2026
InsiderLSLorrain Daniel S.Sell $63KMar 2, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.7M(+11.7%)$35.6M0.0%+30.03%
32
Decreased
1.8M(-2.1%)$24M0.0%-3.99%
0
Decreased
1.7M(-8.5%)$22M0.0%+30.76%
0
Increased
1.5M(+84.8%)$20.1M0.0%+25.01%
44
Unchanged
1.4M$18.6M0.1%+29.39%
0
Decreased
1.3M(-40.5%)$16.9M0.2%+28.63%
0
New
1.2M$15.9M0.0%+7.73%
39
Unchanged
814,871$10.6M0.0%+16.60%
0
Unchanged
669,337$8.7M0.5%-13.74%
0
Increased
669,123(+24.8%)$8.7M0.0%+19.09%
34
Increased
371,636(+39.8%)$4.9M0.0%+25.66%
36
New
350,200$4.6M0.0%+7.73%
37
Increased
307,108(+190.8%)$4M0.0%+19.67%
43
Increased
282,038(+31.9%)$3.7M0.0%+12.34%
34
Increased
232,534(+439.8%)$3M0.0%+11.69%
43
Increased
230,409(+15.6%)$3M0.0%+26.70%
30
Increased
226,302(+25.2%)$3M0.0%+26.36%
32
New
153,924$2M0.0%+7.73%
36
Increased
144,009(+30.8%)$1.9M0.0%+14.38%
33
Increased
107,380(+284.3%)$1.4M0.0%+13.38%
41

Showing 1-20 of 57

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used